53 3-months follow up in patients with cystic fibrosis homozygous for F508Del-CFTR undergoing lumacaftor and ivacaftor (LUM/IVA) therapy showed improvements in intestinal inflammation marker
Poplawska, K, Baehner, V, Schlotter, S, Nitsche, O
Published in Journal of cystic fibrosis (01.06.2017)
Published in Journal of cystic fibrosis (01.06.2017)
Get full text
Journal Article
High antibiotic prescription rates in hospitalized children with human metapneumovirus infection in comparison to RSV infection emphasize the value of point-of-care diagnostics
Schreiner, D., Groendahl, B., Puppe, W., Off, H. Naraghi Taghi, Poplawska, K., Knuf, M., Meyer, C. U., Reischl, A. T., Gehring, Stephan
Published in Infection (01.04.2019)
Published in Infection (01.04.2019)
Get full text
Journal Article
41 Effects of combined exercise training during hospitalization in patients with cystic fibrosis
Stössel, S, Nitsche, O, Schlotter, S, Faber, J, Poplawska, K
Published in Journal of cystic fibrosis (01.06.2016)
Published in Journal of cystic fibrosis (01.06.2016)
Get full text
Journal Article
141 Multi-country comparison of reported disease burden among patients (pts) with cystic fibrosis (CF) who are homozygous for the F508del-CFTR mutation
O'Sullivan, A.K, Wagener, J, Berthiaume, Y, Poplawska, K, Salvatore, D, Prados, C, Middleton, P.G
Published in Journal of cystic fibrosis (01.06.2016)
Published in Journal of cystic fibrosis (01.06.2016)
Get full text
Journal Article
Neonatal respiratory insufficiency caused by an (homozygous) ABCA3-stop mutation: a systematic evaluation of therapeutic options
Winter, J, Essmann, S, Kidszun, A, Aslanidis, C, Griese, M, Poplawska, K, Bartsch, M, Schmitz, G, Mildenberger, E
Published in Klinische Padiatrie (01.04.2014)
Published in Klinische Padiatrie (01.04.2014)
Get more information
Journal Article
P034 Long-term elexacaftor/tezacaftor/ivacaftor CFTR modulation significantly increases lung function and peak power output in people with cystic fibrosis
Hillen, B., Legat, L., Knoll, R.L., Süß, V., Nitsche, O., Simon, P., Poplawska, K.
Published in Journal of cystic fibrosis (01.06.2022)
Published in Journal of cystic fibrosis (01.06.2022)
Get full text
Journal Article
P247 ETI reduces antibiotic treatment days in people with cystic fibrosis – a real-life observation
Beck, L.M., Knoll, R.L., Robert, E.K., Legat, L., Cloos, L., Süß, V., Hillen, B., Nitsche, O., Gehring, S., Poplawska, K.
Published in Journal of cystic fibrosis (01.06.2023)
Published in Journal of cystic fibrosis (01.06.2023)
Get full text
Journal Article
WS12.2 Evolution of inflammatory parameters during CFTR-modulator therapy with lumacaftor/ivacaftor in children aged 6 to 12 years
Rössler, J., Knoll, R.L., Wirsching, S., Cacicedo, M.L., Mildenberger, P., Gehring, S., Nitsche, O., Poplawska, K.
Published in Journal of cystic fibrosis (2021)
Published in Journal of cystic fibrosis (2021)
Get full text
Journal Article
P233 Wanted: Pseudomonas and Staphylococcus - new diagnostic approaches in cystic fibrosis! Is 16S rRNA gene sequencing an equivalent diagnostic tool to conventional microbiology?
Knoll, R.L., Robert, E.K., Rossow, V., Hilbert, K., Beck, L.M., Wanka, P., Cloos, L., Hillen, B., Süß, V., Nitsche, O., Jarquín-Diaz, V.H., Gehring, S., Forslund, S.K., Poplawska, K.
Published in Journal of cystic fibrosis (01.06.2023)
Published in Journal of cystic fibrosis (01.06.2023)
Get full text
Journal Article
P179 A personalised internet-supported exercise and nutrition program increases Resolvin-D1 plasma levels
Knoll, R.L., Hillen, B., Wirsching, S., Klopp, J., Kemper, A., Gruca, S., Bähner, V., Gehring, S., Nitsche, O., Poplawska, K.
Published in Journal of cystic fibrosis (01.06.2020)
Published in Journal of cystic fibrosis (01.06.2020)
Get full text
Journal Article
WS13.3 Microbiome composition during a personalised internet-supported exercise and nutrition program
Knoll, R.L., Klopp, J., Diaz, V.H.J., Hilbert, K., Hillen, B., Kemper, A., Gruca, S., Bäehner, V., Marko, L., Gehring, S., Nitsche, O., Forslund, S.K., Poplawska, K.
Published in Journal of cystic fibrosis (2021)
Published in Journal of cystic fibrosis (2021)
Get full text
Journal Article
170 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from an open-label extension study
Griese, M., Tullis, E., Chilvers, M., Fabrizzi, B., Jain, R., Legg, J., Mall, M., McKone, E., Polineni, D., Poplawska, K., Robinson, P., Taylor-Cousar, J., Ahluwalia, N., Doolittle, C., Jennings, M., Moskowitz, S., Prieto-Centurion, V., Tan, Y.V., Tian, S., Vinarsky, V., Weinstock, T., Xuan, F., Ramsey, B., Daines, C.
Published in Journal of cystic fibrosis (01.10.2022)
Published in Journal of cystic fibrosis (01.10.2022)
Get full text
Journal Article
Einfluss einer neuen Primärversorgungsstrategie und Implementierung volumenorientierter Beatmungsrichtlinien auf die Rate der BPD bei Frühgeborenen unter 1500g (VLBW)
Poplawska, K, Cloppenburg, E, Seidenberg, J
Published in Zeitschrift für Geburtshilfe und Neonatologie (13.11.2006)
Published in Zeitschrift für Geburtshilfe und Neonatologie (13.11.2006)
Get full text
Conference Proceeding
Einfluss einer neuen Primärversorgungsstrategie und Implementierung volumenorientierter Beatmungsrichtlinien auf die Rate der BPD bei Frühgeborenen unter 1500g (VLBW)
Poplawska, K, Cloppenburg, E, Seidenberg, J
Published in Zeitschrift für Geburtshilfe und Neonatologie (18.05.2006)
Published in Zeitschrift für Geburtshilfe und Neonatologie (18.05.2006)
Get full text
Conference Proceeding